Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola

NCT04186000 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
699
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universiteit Antwerpen

Collaborators